Stimulating platelet production with romiplostim is an effective strategy for managing patients with ITP. Thrombocytopenias can be caused by increased platelet destruction, decreased platelet ...
TipRanks on MSN26d
Kissei’s Tavalisse Gains Approval in South Korea for Chronic ITPKissei Pharmaceutical Co ( ($JP:4547) ) has issued an update. Kissei Pharmaceutical Co., Ltd. announced that its partner, JW Pharmaceutical ...
Radiolabeled platelet survival studies cemented the dogma that ITP was primarily due to increased platelet removal by the spleen. Consistent with this idea, platelet transfusion, commonly used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback